MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Nasdaq (NASDAQ:NDAQ) is building its equities and financial technology businesses around an “always-on” market model that it believes can expand investor access while maintaining regulatory oversight, President Tal Cohen said at the Future of Commerce conference hosted by Autonomous.
Cohen said the
DraftKings stock fell 7.6% after data showed Kalshi's NFL Week One prediction market share, but adjusted figures and Kalshi's growing legal risk suggest the gap is smaller than headlines indicate.
Take-Two Interactive shares are down YTD ahead of Grand Theft Auto 6's Nov. 19 launch, but analysts hold a Moderate Buy rating with over 40% implied upside despite ongoing losses.
Vistry Group (LON:VTY) outlined a broad restructuring plan following a CEO review that will reduce its operating footprint, reshape its land bank and shift the business toward a more selective mixed-tenure housing model.
Chief Executive Adam Daniels, who took the role in April, said the review foun
Nasdaq (NASDAQ:NDAQ) CFO Sarah Youngwood said the company’s decade-long expansion beyond its exchange operations has positioned it to benefit from the convergence of cloud computing, artificial intelligence and distributed-ledger technology across financial markets.
Speaking at a company event, You
DFS Furniture (LON:DFS) reported higher revenue, profit and free cash flow for fiscal 2026, citing gross-margin expansion, cost discipline and continued market-share gains despite a subdued upholstery market.
The company said revenue rose 2.6% to just under £1.06 billion. Underlying profit before t
Helus Pharma, formerly known as Cybin (NASDAQ:HELP), outlined its late-stage development plans for HLP-003 in adjunctive major depressive disorder (MDD) and discussed its broader pipeline of serotonergic agonists during TD Cowen’s Novel Mechanisms in Neuropsychiatry virtual summit.
Michael Halstead
Aurora Innovation (NASDAQ:AUR) used its 2026 Analyst and Investor Day to outline plans to expand its driverless trucking operations, scale hardware production and pursue an asset-light Driver-as-a-Service model aimed at supporting more than 30,000 trucks by 2030.
Co-founder and CEO Chris Urmson sai
Conagra Brands (NYSE:CAG) shareholders elected all 11 director nominees, approved executive compensation, ratified KPMG LLP as the company’s independent auditor for fiscal 2027, and approved a shareholder proposal limiting the board’s authority to issue blank-check preferred stock at the company’s 2
CVS Group (LON:CVSG) reported higher revenue, adjusted EBITDA and adjusted earnings per share for the year ended June 30, 2026, while highlighting softer U.K. companion-animal demand late in the year and continued expansion in Australia.
Revenue rose 5.9% to £712.8 million, supported by acquisition
Lifevantage (NASDAQ:LFVN) executives outlined a turnaround plan centered on strengthening the company’s brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion.
President and CEO Terrence Moorehead, who recently joined the company,
Definium Therapeutics (NASDAQ:DFTX) Chief Medical Officer Dan Karlin said the company’s recent Phase III results for DT120 showed statistically significant improvements in generalized anxiety disorder, or GAD, and major depressive disorder, or MDD, following a single treatment, with longer-term open
Darden Restaurants (NYSE:DRI) shareholders elected all nine nominees to the company’s board of directors and approved each management proposal presented at the company’s 2026 annual meeting, according to preliminary voting results announced during the virtual event.
Chair Cindy Jamison said the com
Marc Rowan, chairman, co-founder and CEO of Apollo Global Management (NYSE:APO), said the firm sees a favorable near-term U.S. economic backdrop, continued demand for private credit and significant opportunities tied to industrial investment, AI infrastructure and retirement products.
Speaking at B
Meta Platforms (NASDAQ:META) used its Connect event to outline an expanded artificial intelligence strategy centered on Muse, a personal agent the company said is designed to help users complete tasks, manage information and interact across devices.
The event’s keynote speaker described personal su
Anheuser-Busch InBev SA/NV (NYSE:BUD) outlined a new medium-term target for 5% to 9% average annual EBIT growth as the brewer shifts its primary performance measure from EBITDA to EBIT, citing improved balance-sheet strength, capital efficiency and an increased focus on organic growth.
Speaking at
Everpure (NYSE:P) outlined an expanded technology strategy centered on what executives called “data primacy,” arguing that artificial intelligence is pushing enterprises to organize IT architectures around data rather than individual applications.
At its financial analyst meeting in Santa Clara, Ch
Everpure (NYSE:P) outlined a strategy centered on expanding its enterprise storage business while pursuing new opportunities in AI infrastructure, data software and hyperscale deployments, with executives projecting accelerated growth and higher profitability through fiscal 2028.
At the company’s i
Stitch Fix (NASDAQ:SFIX) reported fiscal 2026 revenue growth and improved profitability, while executives said a more challenging consumer environment, higher client acquisition costs and temporary first-quarter issues are expected to weigh on fiscal 2027 results.
For fiscal 2026, revenue rose 6.4%
Qualcomm (NASDAQ:QCOM) used the second day of its Snapdragon Summit to outline its vision for “personal AI,” highlighting new on-device AI software, wearable reference designs, audio platforms and partnerships intended to support agentic experiences across phones, PCs, cars, glasses and other connec
NeoVolta (NASDAQ:NEOV) said fiscal 2026 marked a strategic shift from a primarily residential battery-storage provider toward a broader energy-storage platform spanning residential, commercial and industrial, and utility-scale markets, though the company reported a sharp fourth-quarter revenue decli
GSK (NYSE:GSK) is advancing a respiratory and immunology pipeline centered on longer-acting biologics, more targeted patient selection and combination approaches, according to Kaivan Khavandi, the company’s senior vice president and global head of Translational and Development Sciences.
Speaking at
Okta (NASDAQ:OKTA) executives said the company is positioning its identity platform to play a central role in securing and governing artificial intelligence agents, arguing that the emerging “agentic” technology market could ultimately exceed the size of today’s identity and access management market
Gevo (NASDAQ:GEVO) is positioning its North Dakota ethanol and carbon sequestration operations as the core of a broader low-carbon fuels and carbon-management business, Chief Executive Officer Paul Bloom said during a Water Tower Research conference session.
Bloom said the company operates a 67-mil
Qualcomm is expanding beyond smartphones with new 2nm chips, the PickNik Robotics acquisition, and data center interconnect deals, while analysts hold a $204 price target amid Hold ratings.
Okta (NASDAQ:OKTA) outlined its strategy for securing artificial intelligence agents at its Oktane event, introducing an industry “Blueprint Alliance,” expanding its Agent SSO standardization efforts and highlighting the generally available Okta for AI Agents platform.
The company said AI agents ca
Evercore ISI upgraded Ciena to Outperform with a $550 target, citing its role in AI data connectivity. The stock has rebounded 17% after strong revenue growth and a backlog nearing $10 billion.
McDonald's (NYSE:MCD) outlined a new multiyear strategy, called McDonald's NEXT, at its 2026 Investor Day, setting targets for share gains in chicken and beverages, restaurant-level productivity improvements and operating-margin expansion through 2030.
Chairman and CEO Chris Kempczinski said the pl
Energy Transfer's revenue, earnings, and distributable cash flow surged after ditching its LNG project, but rising debt and a Texas Stock Exchange move add risk for investors.
Viking Therapeutics shares jumped 36% after VK2735 maintenance data showed patients kept most weight loss on less frequent dosing, though Phase 3 results and commercial funding remain unresolved.
At its Capital Markets Day, Anheuser-Busch InBev SA/NV (NYSE:BUD) emphasized its corporate culture, long-term growth strategy and U.S. sales capabilities, with CEO Michel Doukeris describing ownership and disciplined execution as central to the brewer’s effort to build an “organic compounding machin
Gold rebounded after briefly dipping on the Fed's rate hike, as central bank buying persists. Newmont, Wheaton Precious Metals, and iShares Silver Trust offer distinct ways to invest in the trend.
Thor Industries stock trades near the low end of its range amid an RV industry slump, but steady dividends, institutional buying, and analyst price targets suggest upside potential ahead.
AGF Management (TSE:AGF.B) reported third-quarter 2026 adjusted diluted earnings per share of CAD 0.49, adjusted EBITDA of CAD 49 million and free cash flow of CAD 39 million, as growth in assets under management and retail sales momentum supported results.
Chief Executive Officer Judy Goldring sai
Regeneron Pharmaceuticals (NASDAQ:REGN) executives highlighted continued growth across key marketed products, a broad late-stage pipeline and an ongoing focus on science-driven business development during a discussion with Bernstein analyst Jeffrey Walch.
Chris Fenimore, Regeneron’s executive vice
Paychex (NASDAQ:PAYX) reported a solid start to fiscal 2027, posting first-quarter revenue growth of 6% and double-digit gains in operating income and earnings per share as growth in its professional employer organization, or PEO, and insurance businesses outpaced expectations.
Total first-quarter
Cintas (NASDAQ:CTAS) reported fiscal 2027 first-quarter revenue of $3.01 billion, up 10.9% from a year earlier and marking the first time the company exceeded $3 billion in quarterly revenue. Organic revenue growth, which excludes acquisitions, foreign currency movements and workday differences, was
Kratos Defense and GE Aerospace ignited their jointly developed GEK800 turbofan engine on Sept. 21, 2026, a milestone for scalable, low-cost drone and cruise missile propulsion.
Moderna (NASDAQ:MRNA) executives emphasized the company’s evolution beyond COVID-19 vaccines during a discussion with Bernstein, highlighting its mRNA platform, personalized cancer vaccine program intismeran, rare-disease pipeline and plans to expand therapeutics development.
Chief Executive Office
Sandisk joined the S&P 100 this week, but analysts say the rally stems more from strong NAND demand and record earnings than index inclusion, even as valuation suggests peak earnings cycle.
NVIDIA, Microsoft, Alphabet, and Palantir are monetizing AI through distinct moats, from hardware and cloud services to advertising and safety-focused data orchestration, driving cash flow and shareholder returns.
Worthington Enterprises (NYSE:WOR) reported a 13% increase in fiscal 2027 first-quarter sales to $344 million, supported by 7% organic growth and $19 million of revenue from recent acquisitions. Adjusted earnings per share rose to $0.82 from $0.78 a year earlier, while adjusted EBITDA increased 10%
Jim DeMare, co-president of Bank of America (NYSE:BAC), said the bank continues to see signs of resilience in the U.S. economy, while identifying relationship expansion, international operations, wealth management and technology as major growth priorities.
Speaking at a conference in London, DeMare
NB Private Equity Partners (LON:NBPE) reported a 1.9% net asset value total return in U.S. dollar terms for the first half, or 3.4% in sterling, as private investment valuation gains offset a limited number of markdowns across the portfolio.
The company also said its August monthly NAV rose 1.7%, p
Cracker Barrel Old Country Store (NASDAQ:CBRL) reported fourth-quarter fiscal 2026 revenue of $849.3 million and adjusted EBITDA of $62.1 million, as the restaurant-and-retail operator cited improving traffic trends, stronger guest metrics and continued momentum in its turnaround efforts.
Adjusted
Pasqal is partnering with USA Rare Earth and Riven Systems to apply quantum computing to rare earth separation chemistry, though Pasqal's stock remains largely untested.
Boeing won a $562 million Navy drone contract and Lockheed Martin secured over $1.3 billion in awards, yet both stocks saw little market reaction due to differing valuation concerns.
Eli Lilly leads Novo Nordisk in GLP-1 market share and analyst sentiment, while Novo pins hopes on its CagriSema catalyst and pipeline to offset patent-cliff pressure and lawsuits.
Elixirr International (LON:ELIX) reported record first-half results for 2026, with revenue rising 25% and adjusted EBITDA increasing 29%, as the consulting firm cited growing demand for artificial intelligence services, deeper client relationships and contributions from recent acquisitions.
Co-Foun
Deutsche Bank Aktiengesellschaft (NYSE:DB) CFO Raja Akram said the lender has started its 2028 strategy cycle strongly, citing a record first half, return on tangible equity close to 12%, continued asset gathering in wealth management and improved momentum in its Corporate Bank.
Akram said Germany’
Corning, Cisco Systems, and Texas Instruments are repositioning around AI infrastructure needs, showing earnings growth, steady margins, dividends, and Moderate Buy analyst ratings with notable upside targets.
Tech stocks broke out this week as the QQQ neared record highs. Microsoft, Atlassian, and Hewlett Packard Enterprise show supportive fundamentals and technical setups that could extend gains if the sector's momentum holds.
General Mills (NYSE:GIS) said its fiscal 2027 first-quarter results came in ahead of its expectations as improved retail trends and early cost-savings progress helped offset continued input-cost pressure. The company reaffirmed its full-year outlook, while emphasizing innovation, supply-chain transf
Teva Pharmaceutical Industries (NYSE:TEVA) is planning for greater financial flexibility after receiving investment-grade ratings from all three major credit rating agencies, President and CEO Richard Francis said at the BofA Global Healthcare Conference.
Francis said the company achieved the miles
SThree (LON:STEM) said its third-quarter performance improved sequentially as contract new-business activity increased, productivity rose and recovery signals broadened across more markets. The STEM-focused recruitment company raised its full-year profit-before-tax expectation to at least £12 millio
AutoZone's earnings showed sustained comps growth, margin gains, and buybacks, with analysts holding a Moderate Buy rating and price targets suggesting more than 30% upside.
Agilent Technologies (NYSE:A) executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company’s Ignite transformation program, during a J.P. Morgan conference discussion.
Chief Executive Offi
GSK (NYSE:GSK) Chief Financial Officer Julie Brown outlined the company’s growth strategy, launch priorities and cost-savings plans during a discussion with Bank of America analyst Sachin Jain following the company’s recent capital markets day.
Brown said GSK’s strategic portfolio review identified
Ceres Power (LON:CWR) said it remains confident of signing a new manufacturing licensee this year as it seeks to capitalize on growing demand for on-site power generation, while reporting progress toward its contracted revenue target and continued cost reductions.
Chief Executive Officer Phil Caldw
Renishaw (LON:RSW) reported higher revenue, profit and margins for fiscal 2026, supported by strong demand for position encoders used in semiconductor equipment and by growth in additive manufacturing.
Revenue rose 14% to £816 million, or 17% at constant exchange rates, while adjusted operating pro
General Motors (NYSE:GM) Chief Financial Officer Paul Jacobson said the automaker remains on track to finish 2026 near the higher end of its full-year guidance after raising its outlook twice this year, citing continued consumer resilience, disciplined inventory management and a broad vehicle portfo
ATI (NYSE:ATI) has transformed its portfolio toward aerospace and defense markets, with those end markets now representing about 70% of total revenue, President and CEO Kim Fields said during a Morgan Stanley aerospace and defense conference panel.
Fields said the company’s shift began in 2019, whe
UBS Group (NYSE:UBS) Chief Executive Officer Sergio Ermotti said proposed Swiss capital rules could impose substantial costs on the bank and create a competitive disadvantage, while also outlining continued progress on the integration of Credit Suisse and growth plans across wealth management.
Spea
UiPath (NYSE:PATH) used its investor day to outline a strategy centered on business orchestration and automation, arguing that enterprises will need governed systems to deploy artificial intelligence across complex business processes.
Founder and CEO Daniel Dines said the company has grown revenue
Barclays (NYSE:BCS) CFO Anna Cross said the bank continues to see resilient conditions among U.K. consumers and businesses, supporting loan growth across retail and corporate banking, while the company invests in technology, expands its U.S. consumer offering and works to reduce its structural cost
Neurocrine Biosciences (NASDAQ:NBIX) outlined its commercial growth priorities, pricing considerations and pipeline plans during a Morgan Stanley discussion, with CEO Kyle Gano emphasizing the company’s efforts to diversify beyond its largest product, INGREZZA.
Gano said China has become both a com
Ocular Therapeutix (NASDAQ:OCUL) said it remains on track to submit a U.S. marketing application for AXPAXLI in the fourth quarter of this year, following what Chief Executive Officer Pravin Dugel described as alignment with the Food and Drug Administration on the company’s planned submission packag
Bank Of Montreal (NYSE:BMO) Chief Financial Officer Rahul Nalgirkar said the bank is seeing stronger client activity and loan demand despite uncertainty surrounding Canada-U.S. trade negotiations, while maintaining its focus on improving returns through core operating performance.
Speaking at an in
Qualcomm (NASDAQ:QCOM) used its Snapdragon Summit 2026 keynote to outline its strategy for “agentic” artificial intelligence, positioning smartphones and other connected devices as personal AI endpoints that can understand context, coordinate tasks and act on users’ behalf.
President and CEO Cristi
Anheuser-Busch InBev SA/NV (NYSE:BUD) used its 2026 Capital Markets Day in St. Louis to outline the next phase of its 10-year strategy, emphasizing organic growth, portfolio expansion, digital platforms and increased capital-allocation flexibility.
Chief Executive Officer Michel Doukeris said the b
KB Home (NYSE:KBH) reported third-quarter fiscal 2026 results that met or exceeded its guidance despite what executives described as a more difficult housing environment marked by rising mortgage rates, affordability pressures, higher resale inventory and cautious consumers.
The homebuilder generat
Fastly (NASDAQ:FSLY) outlined a strategy centered on expanding its unified edge cloud platform, increasing multi-product adoption, broadening its geographic reach and targeting revenue of $1.1 billion to $1.3 billion by 2029 at its Investor Day.
Chief Executive Officer Kip Compton said the company
Abeona Therapeutics (NASDAQ:ABEO) highlighted the early commercial progress of ZEVASKYN, its autologous gene-modified cellular sheet therapy for recessive dystrophic epidermolysis bullosa (RDEB), during the H.C. Wainwright 28th Annual conference.
Madhav Vasanthavada, Abeona’s senior vice president
Compass Pathways (NASDAQ:CMPS) said it remains on track to complete its rolling New Drug Application submission for COMP360 in the fourth quarter of 2026, following positive Phase III studies of its synthetic psilocybin treatment in treatment-resistant depression, or TRD.
During H.C. Wainwright’s G
